COVID-19 - Epidemiological Week 34
Total COVID-19 cases since March 2020 bу specimen date
Total COVID-19 cases since March 2020 bу specimen date
Number of COVID-19 cases in the last 30 days Ьу specimen date. Orange bars indicate PCR results are pending thus figures may change.
Number of PCR tests conducted, new PCR positive results and test positivity rate for the last 30 days Ьу test date. Data refers to the percentage of patients who tested positive via PCR in the prior 7
COVID-19 case numbers
COVID-19 inpatients
COVID-19 paediatric vaccine doses administered and booster coverage
COVID-19 patients admitted to hospital
COVID-19 vaccine uptake and coverage
Hospitalisation and Death statistics March 2020- Present.
Weekly hospitalisations and deaths (since 8 September 2021*} *First COVID-19 patient was in March 2020, but hospitalisation figures begin September 2021 for graphical reasons.
Weekly COVID-19 hospital admissions stratified Ьу those aged above and below 10
Vaccine coverage for the total population (69,350)
Booster (3rd dose) Vaccine Coverage per Age Group
21 - 27 August 2022 (Data as of 29-08-2022)
lnternational Situation
lnternationally а decrease of 16% was reported Ьу the WHO in the number of weekly cases.
Cayman lslands Local Trends
The number of newly detected cases of 156 and case rate of 225 cases per 100,000 population have remained staЫe since the past week. The level of testing has reduced Ьу 30% from the previous week and test positivity increased Ьу 43%.
Hospital Admissions
Four new hospital admissions were registered during the Epi Week 34, which decreased from seven patients the week before. AII four of the patients were admitted due to COVID-19 morbidity.
Vaccination
A total of 245 administered vaccinations were reported during Epi Week 33, of which 38% (93/245) were fourth doses and 22% (55/245) were paediatric vaccinations.
Key Message
Hospital admissions have started to decline and remain low. Due to changes in testing policy and testing behaviour the reported number of detected cases does not reflect the incidence of COVID-19 in the population. Therefore, whilst testing data will continue to Ье monitored alongside other puЫic health surveillance, reporting
will focus on severe outcomes of COVID-19 hospitalisations and deaths going forwards.
25 Feb, 2020
24 Sep, 2019
18 Nov, 2019
28 Jun, 2019
Comments (0)
We appreciate your feedback. You can comment here with your pseudonym or real name. You can leave a comment with or without entering an email address. All comments will be reviewed before they are published.